Genetic Screening Project Launches for Brazilian Parents

Key Summary

• • Brazil is launching the Our Genes Project, a nationwide genetic screening program for prospective parents.
  • The initiative will identify couples at risk of passing on recessive genetic disorders and Fragile X syndrome.
  • Researchers aim to build a large-scale Brazilian genomic database to improve polygenic risk scores and precision medicine.
  • Current global genetic databases are heavily based on European populations, limiting accuracy for Brazil’s genetically diverse population.
  • The project complements national efforts such as Genoma SUS, which has already sequenced over 21,000 genomes.
  • Explore All CME Conferences & Online Courses in Genetics and Precision Medicine

Why Is Brazil Investing in a National Genetic Screening Project?

Brazil is preparing to launch a major genetic screening project designed to help prospective parents better understand inherited disease risks while strengthening the country’s precision medicine capabilities. The initiative, known as Our Genes, will soon begin recruiting volunteers through a collaboration involving the Human Genome and Stem Cell Research Center (HUG-CELL), the University of Brasília, the Federal University of Bahia, the Federal University of Espírito Santo, and several research partners.

The program will offer voluntary testing for genes associated with recessive genetic disorders and Fragile X syndrome, one of the leading inherited causes of intellectual disability. Through genetic counseling, couples found to carry disease-causing variants in the same gene will receive information about their reproductive risks and available options.

For healthcare professionals, genetic counselors, nurses, and public health stakeholders, the initiative highlights the growing role of genomics in preventive care and reproductive health planning.

How Will the Genetic Screening Program Improve Disease Prediction?

Beyond reproductive screening, the project seeks to create a comprehensive genomic database that reflects Brazil’s unique genetic diversity. Researchers plan to use the data to develop more accurate polygenic risk scores, which estimate an individual’s likelihood of developing common conditions such as diabetes, hypertension, and cardiovascular disease.

Current risk prediction models are largely based on European populations, creating challenges when applied to highly admixed populations like Brazil. This limitation can lead to inaccurate disease risk estimates and reduced diagnostic precision for patients from underrepresented genetic backgrounds.

The initiative builds on previous efforts such as the Brazilian Online Mutation Archive (ABraOM), a public genomic database containing information from healthy older adults. ABraOM helps clinicians distinguish harmless genetic variations from potentially disease-causing mutations, improving the efficiency of rare disease diagnosis.

Why Are Population-Specific Genomic Databases Important?

Population-specific genomic databases improve diagnostic accuracy, strengthen disease risk prediction, and support the development of precision medicine strategies tailored to local populations.

Strengthening Genomic Research and Data Sovereignty

The launch of the Our Genes project aligns with Brazil’s broader Genoma SUS Program, a national effort to integrate genomic medicine into the country’s public healthcare system. Since its launch, Genoma SUS has sequenced more than 21,000 complete genomes, with plans to add another 50,000 over the next two years.

Researchers emphasize that generating local genomic data is essential for improving healthcare outcomes and ensuring scientific independence. In addition to supporting clinical diagnostics, Brazilian genomic research may uncover novel biological pathways associated with conditions such as Alzheimer’s disease and lipid metabolism disorders, potentially leading to future therapeutic discoveries.

Explore All CME Conferences & Online Courses in Genetics and Precision Medicine

As precision medicine becomes increasingly important worldwide, Brazil’s investment in genomic infrastructure could serve as a model for other nations seeking to improve healthcare through population-specific genetic research.

Source:

São Paulo Research Foundation (Fundação de Amparo à Pesquisa do Estado de São Paulo)